MDRX (Veradigm) Other Long Term Assets: $48.5 Mil (As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MDRX Veradigm Inc MDRX
23 GF Score
Price $4.65
View Full Analysis

What is Veradigm Other Long Term Assets?

Veradigm MDRX -4.12% 23 Other Long Term Assets is $48.5 Mil as of Dec. 2022. GuruFocus rates MDRX with a GF Score™ of 23/100.

Veradigm's other long-term assets for the quarter that ended in Dec. 2022 was $48.5 Mil.

Veradigm's quarterly other long-term assets increased from Dec. 2020 ($105.3 Mil) to Dec. 2021 ($839.9 Mil) but then stayed the same from Dec. 2021 ($839.9 Mil) to Dec. 2022 ($48.5 Mil).

Veradigm's annual other long-term assets increased from Dec. 2020 ($105.3 Mil) to Dec. 2021 ($839.9 Mil) but then declined from Dec. 2021 ($839.9 Mil) to Dec. 2022 ($48.5 Mil).

Veradigm Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Veradigm's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veradigm Other Long Term Assets Chart

Veradigm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 573.03 105.30 839.87 48.45 36.30

Veradigm Semi-Annual Data
Dec03 Dec04 Dec05 Dec06 Dec07 May09 May10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 573.03 105.30 839.87 48.45 36.30
MDRX
23GF Score
Veradigm Inc MDRX
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veradigm Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of $48.5 Mil mean?
Veradigm (MDRX) has a Other Long Term Assets of $48.5 Mil as of Dec. 2022. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Veradigm and its competitors.
Is Veradigm's Other Long Term Assets too high?
Veradigm's current Other Long Term Assets is $48.5 Mil. Overall, Veradigm has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Veradigm's Other Long Term Assets compare to WEAV and PHR?
Veradigm's Other Long Term Assets of $48.5 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Healthcare Providers & Services company?
A good Other Long Term Assets depends on the Healthcare Providers & Services industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Veradigm and its competitors. Veradigm's current Other Long Term Assets is $48.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veradigm stock overvalued right now?
Veradigm (MDRX) has a current Other Long Term Assets of $48.5 Mil. The current Other Long Term Assets is $48.5 Mil. Veradigm's overall GF Score™ is 23/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Veradigm (MDRX), the current Other Long Term Assets is $48.5 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veradigm Business Description

Address 222 Merchandise Mart Plaza, Suite 2024, Chicago, IL, USA, 60654
Veradigm Inc together with its subsidiaries, is a healthcare software-as-a-service (SaaS) technology, data and analytics company spanning the three pillars of healthcare: Provider, Payer and Life Science. Its Provider segment represents the source of revenue, followed by the Payer segment, with the Life Science segment contributing a comparatively smaller portion. Its portfolio addresses a range of healthcare industry needs, with the goal of transforming health insightfully, providing key healthcare stakeholders with data, insights and artificial intelligence (AI) enhanced solutions to help improve health outcomes and reduce costs.
23GF Score

Get the complete analysis for MDRX

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.65
Price